Skip to content

BioSenic (formerly Bone Therapeutics) uploaded a News Release
October 20, 2020

Follow

Bone Therapeutics reaches 50% treated patients in ongoing JTA-004 Phase III pivotal knee osteoarthritis study

  • Recruitment on track to be completed before year-end
About Us | Please read our Privacy Policy, Cookie Policy, Disclaimer and Terms and Conditions. By accessing or using the Service you agree to be bound by these Terms. © 2024 Arrowhed Business and Investment Decisions, LLC.